This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
4-AcO-MET: Difference between revisions
>Josikins m Text replacement - "*'''Effect::Delusions'''" to "*'''Effect::Delusion'''" |
>Unity Content standardization and formatting. |
||
| Line 55: | Line 55: | ||
====[[Effect::Geometry]]==== | ====[[Effect::Geometry]]==== | ||
The visual geometry | The visual geometry presented by 4-AcO-MET is similar in appearance to that of [[psilocin]], [[4-AcO-DMT]] and [[4-HO-MiPT]] but with stronger "synthetic" digital undertones comparable to [[2C-B]]. 4-AcO-MET can be comprehensively described through its [[Geometry#Variations|variations]] as intricate in complexity, abstract in form, equally synthetic and organic in style, structured in organization, extremely brightly lit and multicolored in scheme, glossy in shading, sharp in edges, large in size, fast in speed, smooth in motion, angular in corners, non-immersive in depth and consistent in intensity. The visuals have a contradictory "synthetic" and "natural" feel to them which is reminiscent of both [[LSD]] and [[psilocybin]] respectively. Higher dosages are significantly more likely to result in states of [[Effect::8A Geometry|level 8A]] visual geometry over [[8B Geometry|level 8B]]. | ||
====Hallucinatory states==== | ====Hallucinatory states==== | ||
| Line 120: | Line 120: | ||
*'''[[Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[paranoia]], [[thought loops]] and [[panic attacks]]. This interaction may cause elevated risk of psychosis.{{citation needed}} | *'''[[Stimulants]]''' - Stimulants affect many parts of the brain. Combined with psychedelics, stimulation can turn into uncontrollable [[anxiety]], [[paranoia]], [[thought loops]] and [[panic attacks]]. This interaction may cause elevated risk of psychosis.{{citation needed}} | ||
*'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of Medical Toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}} | *'''[[Tramadol]]''' - Tramadol lowers the seizure threshold<ref>Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of Medical Toxicology, 5(2), 63-67. doi:10.1007/BF03161089</ref> and [[psychedelics]] may act as triggers for seizures, particularly in those who are predisposed to them.{{citation needed}} | ||
==Legal status== | ==Legal status== | ||
{{legalStub}} | {{legalStub}} | ||
*'''United Kingdom:''' 4-AcO-MET is a Class A drug in the UK as it is an ester of the drug [[4-HO-MET]]<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) | http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I/paragraph/3</ref>, which is a Class A drug as a result of the tryptamine catch-all clause.<ref>Misuse of Drugs Act 1971 (Legislation.gov.uk) |http://www.legislation.gov.uk/ukpga/1971/38/schedule/2/part/I#reference-M_F_c7632653-ddad-4420-f307-e3da1e36d30e</ref> | |||
*'''United Kingdom''' | *'''United States:''' 4-AcO-MET is unscheduled in the United States. It may be considered an analogue of [[psilocin]] (''4-HO-DMT'') which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption or the use for illicit non-medical or industrial intents and purposes could be prosecuted as crimes under the Federal Analogue Act.{{citation needed}} | ||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research | *[[Research chemicals]] | ||
*[[ | *[[Psychedelics]] | ||
*[[Tryptamine]] | *[[Tryptamine]] | ||
*[[4-HO-MET]] | *[[4-HO-MET]] | ||